ClinConnect ClinConnect Logo
Search / Trial NCT05404386

Effect of Mobile Application on Urinary Incontinence

Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Jun 1, 2022

Trial Information

Current as of November 09, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study tests whether a smartphone app called “My Fight with Incontinence” can help women with urinary incontinence (leakage) reduce symptoms, improve how well they do pelvic floor (Kegel) exercises, and boost quality of life. It is a randomized, single-blind trial (women don’t know their group) that compares 3 months of using the app with usual care versus a control group that receives a training booklet. Researchers will measure changes in leakage severity and related symptoms at 6 and 12 weeks, as well as impact on daily life, Kegel exercise adherence, and overall well-being. The study is being done at Eskişehir Osmangazi University in Turkey, and about 96 adult women are planned to participate.

To be eligible, you would need to be a female aged 18–65 with urinary incontinence (stress, urge, or mixed type), have an Android smartphone, be literate, and have a body mass index (BMI) under 30. You must consent to participate and not have certain exclusions, such as recent pelvic surgery or childbirth within the last several weeks, significant physical or mental disabilities, or other conditions that would make participation difficult. If enrolled, you’ll be randomly assigned to either the app group or the control group and will complete questionnaires at baseline, 6 weeks, and 12 weeks to track symptoms, exercise use, beliefs about urinary health, and quality of life. Results from this trial are not available yet.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Volunteer to participate in the research
  • Being a female
  • Being in the age range of 18-65
  • Using a smart mobile phone (for communicating via Whatsapp and installing a mobile application to the workgroup)
  • BMI \< 30kg/m2
  • Being literate
  • Having a diagnosis of urinary incontinence (stress, emergency/urge, mixed type)
  • Exclusion Criteria:
  • Those who do not have an Android-based smartphone
  • Have a physical or mental disability
  • Those who have undergone vaginal and pelvic operations within 6 months
  • Have given birth within 12 weeks
  • Having a history of miscarriage within 6 weeks
  • Those who have had recurrent vaginitis infections
  • History of the cardiac implant or untreated cardiac arrhythmia
  • Having a communication barrier

About Eskisehir Osmangazi University

Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.

Locations

Eskişehir, Odunpazarı, Turkey

Eskişehir, Turkey

Patients applied

0 patients applied

Trial Officials

Pınar Duru, PhD

Principal Investigator

Department of Public Health Nursing, Eskisehir Osmangazi University, Turkey

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials